Patients with hidradenitis suppurativa (HS) may have subclinical spondyloarthritis (SpA) features, e.g., sacroiliitis and ...
The final quarter of 2025 delivered a broad spectrum of clinical momentum across autoimmune disease, oncology, neurology, infectious disease, and cardiopulmonary medicine. Several programmes produced ...
Rozanolixizumab for treating antibody-positive generalised myasthenia gravis [ID5092] Technology appraisal guidance TBC Ruxolitinib for treating moderate to severe chronic graft-versus-host disease ...
Elamipretide for treating Barth syndrome in people of any age [ID6545] Technology appraisal guidance Elinzanetant for treating vasomotor symptoms associated with menopause [ID6359] Technology ...
Novartis' phase III PREVENT trial of Cosentyx in patients with nr-axSpA meets primary endpoint: Basel Wednesday, November 13, 2019, 09:00 Hrs [IST] Novartis, a leader in rheumatol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback